The source and target and the mechanism of IL-3 signaling in the pathology of AD have recently been clearly demonstrated by McAlpine et al. using IL-3 knockout mice crossing with 5X FAD mice, and tissue from the frontal cortex of AD patients [87]. This evidence concerns the gene IL3 and Alzheimer disease.